ISPOR HEALTH TECHNOLOGY ASSESSMENT ROUNDTABLE PARTICIPANTS

Argentina

David Aruachan, MD (2017)
Chief of Staff, Superintendence of Health Services, Superintendencia de Servicios de Salud, Buenos Aires, Argentina

Federico Augustovski, MD, MSc (2009, 2014 – 2017) Director, Health Economic Evaluation and Technology Assessment, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina

Dr. Juan Pablo Denamiel (2014 – 2015) Deputy Superintendent of Strategic Management in Health Services, Ministry of Health, Buenos Aires, Argentina

Sebastián Garcia Marti, MD, MSc (2015) Coordinator, Economic Evaluations & HTA, IECS, Buenos Aires, Argentina

Natalia Jorgensen, BEc, MSc (2017) Associate Manager of Cost Assessment, Argentinean Health Superintendence, Buenos Aires, Argentina

Andres Pichon-Riviere, MD, MSc, PhD (2009, 2011, 2013, 2015) Executive Director, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

Tomas Pippo, MS (2011, 2013) Director, Health Economics Department Ministry of Health, Buenos Aires, Argentina

Adolfo Rubinstein, MD, MSc, PhD (2009) President, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina

Ruben Torres, MD (2017)
Dean, Centro de Evaluación de Tecnologías Sanitarias (CETSA), Universidad ISALUD, Buenos Aires, Argentina

Guillermo Williams, MD (2011, 2013) Director, National Board of Health Regulations and Quality Health Care, Ministry of Health, Buenos Aires, Argentina

 

Australia

Josh Byrnes, PhD (2015) Research Fellow of Health Economics, School of Medicine, Griffith University, Queensland, Australia

Andrew Mitchell (2016)
Pharmaceutical Evaluation Branch/Pharmaceutical Benefits Division, Medical Specialist Services Branch/Medical Benefits Division, Department of Health, Canberra, Australia

Rosalie Viney, PhD (2008) Associate Professor in Health Economics, Centre for Health Economics Research and Evaluation, Sydney, Australia

 

Austria

Gottfried Endel, MD (2009 – 2015) Head, HTA Department, Main Association of Austrian Social Security Institutions, Vienna, Austria

Ingrid Wilbacher, PhD (2016)
Senior Researcher, Department for Evidence Based Economic Health Care, Main Association of Austrian Social Security Institutions, Vienna, Austria

Claudia Wild, PhD, Priv-Doz (2016)
Director, Ludwig Boltzman Institute for Health Technology Assessment (LBI-HTA), Vienna, Austria

 

Belarus

Liliya I. Nadolnik, PhD (2010 - 2011) Director, Branch Office of the Republican Centre for Technology Transfer, Research and Production Centre Institute of Pharmacology and Biochemistry, National Academy of Sciences of Belarus, Grodno, Belarus

Maryna M. Sachek, MD, PhD (2012 - 2014) Director, Republican Scientific & Practical Center of Medical Technologies, Grodno, Belarus

 

Belgium

Francis Arickx (2015 – 2016) Head, Directorate Pharmaceutical Policy, National Institute for Health and Disability Insurance (RIZIV INAMI), Brussels, Belgium

Mary Baker, MBE (2012) President, European Brain Council, Brussels, Belgium

Jérôme Boehm, MBA (2009, 2014) Head of Pharmaceuticals Sector, Health and Consumers Directorate General, DG SANCO, EU Commission, Brussels, Belgium

Flora Giorgio (2013) Policy Officer, DG SANCO, EU Commission, Brussels, Belgium

Dirk Ramaekers, MD, PhD (2007) Director, Belgian Health Care Knowledge Centre, Brussels, Belgium

Liuska Sanna (2012) Programme Manager, European Patients' Forum (EPF), Brussels, Belgium

Dominik Schnichels (2016)
Head of Unit, DG Sante, European Commission, Brussels, Belgium

Anders Lamark Tysse (2010 - 2012) Policy Officer, Health and Consumers Directorate General, DG SANCO, EU Commission, Brussels, Belgium

 

Bosnia and Herzegovina

Tarik Catic, MSc Pharm (2010 - 2014) President, ISPOR Bosnia-Herzegovina Regional Chapter, Sarajevo, Bosnia i Herzegovina

Vladimir Guzvic, MD, PhD (2015 – 2016) Medical Doctor, Department of Clinical Pharmacology, Health Insurance Fund, Banja Luka, Bosnia and Herzegovina

 

Brazil

Giacomo Balbinotto, PhD (2009) Professor Adjunto de Economia da Saúde, Federal University of Rio Grande do Sul, Rio de Janeiro, Brazil

Rosângela Caetano, MD, PhD (2009) Coordenadora do Mestrado Profissional de Gestão e Avaliação de Tecnologias em Saúde, UERJ e DECIT/MS, Rio de Janeiro, Brazil

Vania Cristina Canuto Santos, MSc (2015, 2017) Substitute Director, National Commission of Incorporation of Technologies, Ministry of Health of Brazil, Brasilia, Brazil

Ana Raquel Dutra, MA (2013) Assessor of the Cabinet, Secretariat of Science, Technology and Strategic Inputs -SCTIE, Ministerio de Salud, Brasilia DF, Brazil

Flávia Tavares Elias, MSc (2009, 2011) Coordinator of HTA and Clinical Research, DCIT/SCTIE, Ministry of Health, Brasília DF, Brazil

Raquel Medeiros Lisbôa, MD (2017)
General Manager for Health Regulation, Agência Nacional de Saúde Suplementar – ANS, Rio de Janeiro, Brazil

Cláudio Maierovitch, MD (2009) Coordinator, CITEC (Commission for Incorporation of New Technologies), Secretariat of Science, Ministry of Health, Brasilia, Brazil

Cid Manso de Mello Vianna, PhD (2009) Director, Instituto de Medicina Social da Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

Clarice Alegre Petramale, MD (2011, 2013) Director, Department of Management & Incorporation of Health Technologies (DGITS), Secretariat of Science, Technology, and Strategic Inputs (SCTIE), Ministry of Health, Brasília DF, Brazil

Tomás Pippo Briant, MSc (2017)
Coordenador da Unidade Técnica de Medicamentos e Tecnologias en Saúde, OPAS/OMS no Brasil, Pan American Health Organization (PAHO), São Paulo, Brazil

Carisi Anne Polanczyk, MD, PhD (2009) Cardiology Service, Clinical Hospital of Porto Alegre – UFRGS, Associate Professor of Medicine, Federal University of Rio Grande do Sul, Rio Grande do Sul, Brazil

Christophe Rérat, MD (2009) Sub-Regional Advisor in Medicines, Vaccines & Health Technology, Organização Panamericana da Saúde - OPAS/OMS, Pan American Health Organization - PAHO/WHO, Brasilia, Brazil

Mauricio Vianna, MBA, MD, MSc (2009) Secretaria de Assistência a Saúde - ATS Coordinator, Ministry of Health, Rio de Janeiro, Brazil

 

Bulgaria

Plamen Dimitrov, MD, PhD, MSc (2015) Head Deputy Director, Department Health System Analysis, National Center of Public Health Protection, Sofia, Bulgaria

 

Canada

Sylvie Bouchard, MPharm, MBA (2017)
Scientific Director, Drug Directorate, National Institute for Excellence in Health and Social Science
(INESSS), Québec, QC, Canada

Tammy Clifford, PhD (2007) Director, HTA Project Quality, Canadian Agency for Drugs & Technologies in Health, (CADTH), Ottawa, ON, Canada

Brent Fraser, MBA, BSc (2016) Vice-President, Pharmaceutical Reviews, Canadian Agency for Drugs and Technologies in Health (CADTH), Toronto, ON, Canada

Mireille M. Goetghebeur, MEng, PhD (2015) President, EVIDEM Collaboration, Adjunct Professor, School of Public Health, University of Montreal, Montreal, Quebec, Canada

Don Husereau, BSc Pharm, MSc (2008, 2014 - 2015, 2017) Senior Associate, Institute of Health Economics and Senior Scientist, University for Health Sciences, Medical Informatics and Technology, and Adjunct Professor, University of Ottawa, Ottawa, ON, Canada

Egon Jonsson, PhD (2008) Director, IHE in Alberta, University of Alberta, Public Health Sciences, Edmonton, AB, Canada

Jean-Marie Lance, PhD (2008 - 2009) Senior Scientific Advisor Director, Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS), Montreal, PQ, Canada

Karen Lee, MA (2016)
Director, Health Economics, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada

Leslie Levin, MB, MD, FRCP, FRCPC (2007 - 2009, 2011, 2014) Vice President, Evidence Development and Standards, Health Quality Ontario, Toronto, ON, Canada

Judy McPhee, BScPharm (2016) Executive Director, Pharmaceutical Services, Department of Health and Wellness, Government of Nova Scotia, Halifax, NS, Canada

Stephen Membe, BA (Hon), MDE (2007) Health Economist, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada

Brian O’Rourke, PharmD (2016 - 2017) President and Chief Executive Director, Canadian Agency for Drugs and Technologies in Health (CADTH) and Chair, The International Network of Agencies for Health Technology Assessment (INAHTA), Ottawa, ON, Canada

Denis A. Roy, MD, MPH, MSc, FRCPC (2016) Vice-President, Science and Clinical Governance, National Institute for Excellence in Health and Social Science (INESSS), Québec, QC, Canada

Chander Sehgal, MD, MBA (2015) Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada

Jill Sanders, PhD (2008 - 2009) President & CEO, Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada

Kevin Wilson (2016 - 2017) Executive Director, Drug Plan and Extended Benefits Branch, Saskatchewan Ministry of Health, Regina, SK, Canada

 

Chile

Rony Lenz Alcayaga, MA (2015) Professor, School of Public Health, University of Chile and Head Consultant, Lenz Consulting, Santiago, Chile

Mónica Aravena Pastén (2017)
Researcher, Department of Sanitary Technologies / Health Planning Division, Ministerio de Salud, Santiago, Chile

Dr. Maria Basagoitia (2015) Strategic Development Department, Ministry of Health, Santiago, Chile

Luis Vera Benavides, MD, MSc (2011) Professional Adviser, Health Technology Assessment, Department of Quality and Patient Safety, Ministry of Health, Santiago, Chile

Hernan Bustamante G., MD, MBA (2009) Director Primary Care, Air Force Chilean Hospital, Health Economy Investigator, Center of Epidemiology and Public Policies, Universidad del Desarrollo, Santiago, Chile

Marianela Castillo Riquelme, MSc (2013, 2015) Head, Department of Health Technology Assessment (HTA), Ministry of Health, Santiago, Chile

Manuel Espinoza, MD, MSc, PhD (2015) Professor, Department of Public Health & Coordinator, Unit of Health Technology Assessment (HTA) Center for Clinical Research, Catholic University of Chile, Santiago, Chile

Pietro Cifuente Parra, MD (2014)
Chief, Department of Planning, FONASA, Santiago, Chile

David Ernesto Debrott Sánchez, MSc (2017)
Head, Department of Studies and Development, Superintendencia de Salud, Santiago, Chile

Emilio Santelices Cuevas, MBA, MD (2011) Chief, Department of Strategic Development, Ministry Cabinet, Ministry of Health, Providencia, Santiago, Chile

Nicolás Silva Illanes, MD, MSc (2017)
Researcher, Pharmacoeconomics & Economics Unit, Escuela de Salud Pública, Universidad de Chile, Santiago, Chile

Jeanette Vega Morales, MD (2014)
Director, FONASA, Santiago, Chile

 

China

Jie Chen, PhD (2008, 2012 - 2014) Director, National Key Lab of Health Technology Assessment, Ministry of Health and Professor, Fudan University, Shanghai, China

Wen Chen, PhD, MD (2008) Professor and Associate Dean, School of Public Health, Fudan University, Shanghai, China

Shanlian Hu, MD, MSc (2008, 2012) Director, Center for Health Development Research, Shanghai Bureau of Health and Professor of Health Economics, School of Public Health, Fudan University, Shanghai, China

Kejun Liu, PhD (2012) Deputy Director, China National Health Development Research Center, Ministry of Health, Beijing, China

Yingpeng Qiu, MA (2013) Research Assistant, Division of Health Technology Assessment, China National Health Development Research Center (NHDRC), Ministry of Health, Beijing, China

Wenge Song (2014) Deputy Director General, Health and Family Planning Commission of Liaoning Province, China

Haiying Wang (2012) Secretary of Director, Center for Health Technology Assessment, Shanghai Municipal Bureau, Shanghai, China

Jinqian Wang (2014) Director, Division of Health Technology Assessment, Department of Science and Education, National Health and Family Planning Commission (NHFPC), Beijing, China

Xiaojuan Yang (2012) Associate Research Fellow, Center for Health Technology Assessment, Shanghai Municipal Bureau, Shanghai, China

Dezhi Yu (2014) Director General, Anhui Provincial Commission of Health and Family Planning, China

Kun Zhao, MD, PhD (2014 - 2016) Professor and Director, Division of Health Technology Assessment, China National Health Development, Research Center, National Health and Family Planning Commission (NHFPC), Beijing, China

 

Colombia

Lizbeth Alexandra Acuña Merchán, MD (2014, 2017)
Executive Director, Cuenta de Alto Costo (CAC), Bogota, Colombia

Jaime Calderón Herrera, MD (2017)
Executive Director, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, Colombia

Mery Concepcion Bolivar Vargas, MD (2011) Advisor to Vice-Minister in Health of HTA, Ministry of Social Protection, Bogota, Colombia

Gabriel Carrasquilla G., MD, MSc, DrPh (2009) Director, Center for Health Care Research Studies (CEIS), Santa Fe de Bogota Foundation, Bogota, Colombia

Hector Eduardo Castro Jaramillo, MD, MSc, PhD(c) (2013, 2017) Director de Medicamentos & Tecnologias en Salud Director of Medicines & Health Care Technologies Ministerio de Salud y Protección Social, Bogota, Colombia

Orlando Gracia Fajardo, MD (2011) Director, Department of Demand Management in Health, Ministry of Social Protection, Bogota, Colombia

Aurelio Mejía, BEc, MSc (2016-2017)
Senior Economist, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, Colombia

Dr. Félix Régulo Nates Solano (2017)
Director de Regulación Beneficios, Costos y Tarifas del Aseguramiento en Salud, Ministerio de Salud y Protección Social, Bogotá, Colombia

Ing. Napoleon Alberto Ortiz Guevara, MSc (2013) President of the Comission ETESA, ORAS, Ministry of Social Proteccion, Bogota, Colombia

Carlos Felipe Prada, MD (2011) Advisor to Minister in Health of HTA, Ministry of Social Protection, Bogota, Colombia

Diego Rosselli, MD (2009) Universidad Jorge Tadeo Lozano, Bogota, Colombia

Luis Guillermo Vélez, MD (2009, 2011) President, Board of Directors of High Expenses in Health, Bogota, Colombia

 

Costa Rica

Dra. Ana Eduviges Sancho Jiménez (2017) Dirección de Desarrollo Científico y Tecnológico en Salud, Ministerio de Salud, San José, Costa Rica

 

Croatia

Mirjana Huić, MD, MSc (2010 -  2016) Assistant Director, Clinical Pharmacologist and Toxicologist, Department for Development, Research and Health Technology Assessment Agency for Quality and Accreditation in Health Care, Zagreb, Croatia

Mirela Pucic, mag.math (2015 – 2016) Coordinator for Economic Affairs, Croatian Institute for Health Insurance, Zagreb, Croatia

 

Czech Republic

Jan Čeněk, MD (2014)

Analyst Ministry of Health of Czech Republic, Prague, Czech Republic

Marketa Hellerova (2010) Representative, Ministry of Health, Prague, Czech Republic

 

Denmark

Anya Brandt, MSc (2016)
Senior Specialist, Business Intelligence & Health Economic, AMGROS, Copenhagen, Denmark

Julia Chamova, MBA (2015) Director of Operations, EUnetHTA, Copenhagen, Denmark

Finn Børlum Kristensen, PhD, MD (2006 - 2017)
Former EUnetHTA Executive Committee Chairman and EUnetHTA Secretariat Director; Professor, Faculty of Health Sciences, University of Southern Denmark, Hillerød, Denmark

Camilla Palmhöj Nielsen (2006) Danish Centre for Evaluation and Health Technology Assessment, Copenhagen, Denmark

 

Ecuador

Felipe Garcia, MBA (2013) Head, Department of Pharmacoeconomics, Superintendency of Health Economics, Ministry of Health, Quito, Ecuador

Ruth Jimbo Sotomayor, MD (2015) Family Physician, Health Technology Assessment, Health Intelligence Management, Ministry of Health, Quito, Ecuador

 

Egypt

Randa Eldessouki, MBBCh, MSc, MD (2014)
Lecturer, Public Health Department, Faculty of Medicine Fayoum University Fayoum, Egypt

 

Estonia

Professor Raul Kiivet (2010) Department of Public Health , University of Tartu, Tallinn, Estonia

Rainer Reile, PhD, MA (2016)
Project Manager, Department of Public Health, University of Tartu, Tartu, Estonia

 

Finland

Jaana Leipälä, MD, PhD (2015 – 2016) General Secretary, Council for Choices in Health Care in Finland / COHERE Finland, Ministry of Social Affairs and Health, Helsinki, Finland

Iris Pastenack, MD (2011 - 2014) Coordinator, University Hospital District of Helsinki and Uusimaa (HUS), Helsinki, Finland

Harri Sintonen, PhD (2006, 2010) Professor of Health Economics, Department of Public Health, University of Helsinki and Finnish Office for Health Technology Assessment (FINOHTA), Helsinki, Finland

 

France

François Meyer, MD (2009 - 2014, 2016) Advisor to the President, International Affairs, Haute Autorité de Santé, Saint-Denis La Plaine, France

Mira Pavlovic, MD (2010) Adjointe au Directeur de l'évaluation médicale, économique et de santé publique, Haute Autorité de Santé, Saint-Denis La Plaine, France

 

Germany

Hannah Brühl, PhD (2016)
Scientific Advisor, Pharmaceuticals Department, Gemeinsamer Bundesausschuss (G-BA, Federal Joint Committee), Berlin, Germany

Hans-Peter Dauben, PhD, MD (2006 -2007) Head, International Affairs, German Institute for Medical Documentation & Information (DIMDI), Cologne, Germany

Peter Kolominsky-Rabas, MD, PhD, MBA (2007 -2008) Head, Department of Health Economics, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), Cologne, Germany

Alric Rüther, MD, PhD (2006 - 2016) Head, International Affairs, Department of Health Care Quality, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), Cologne, Germany

Doris C. Schmitt (2012) PR Manager, German Breast Cancer Association, Board Member, Foundation PATH, Radolfzell, Germany

Regina Skavron, MD (2015) Scientific Officer, Pharmaceuticals Division, Gemeinsamer Bundesausschuss (G-BA, Federal Joint Committee), Berlin, Germany

 

Greece

Elpida Pavi DDS, MPH, PhD (2010 - 2011) Senior Lecturer, EUnetHTA JA, Representative of Greece, National School of Public Health, Athens, Greece

 

Guatemala

Pamela de la Rosa, MBA (2009) Committee Leader for the Development of Guidelines, Program Accessibility Drug PROAM, Ministry of Health, Guatemala, Guatemala C.A.

 

Hungary

László Gulácsi, PhD (2008) Director, Health Economics and HTA Research Centre, Corvinus University, Budapest, Hungary

László Nagyjánosi, PhD, MSc (2016)
Head, Health Technology Assessment Division, National Institute of Pharmacy and Nutrition (OGYÉI), Budapest, Hungary

Bertalan Németh, MSc (2013-2014) Health Economist, National Institute for Quality and Organizational Development in Healthcare, Budapest, Hungary

 

India

Jitendar Sharma, PhD (2013 - 2016) CEO, Andhra Med Tech Zone (AMTZ), and Director, WHO Collaborating Centre for Priority Medical Devices & Health Technology Policy, National Health Systems Resource Centre, Ministry of Health & Family Welfare, New Delhi, India

 

Indonesia

Nasirah Bahaudin (2013) Former Director, Office of Ministry of Health, Jakarta, Indonesia

Agusdini Banun, B.Pharm, MHA (2013 - 2015) Secretary for Directorate General of Pharmaceutical Products and Medical Devices Development, Ministry of Health, Jakarta, Indonesia

Erie Gusnellyanti, BPharm, MPH (2013 - 2016) Head of Section for Monitoring and Evaluation of Rational Use of Medicines, Directorate of Pharmaceutical Services, Jakarta, Indonesia

Ira Miranti (2013) Pharmaceutical Services, Office of Ministry of Health, Jakarta, Indonesia

Engko Sosialine Magdalene, Apt, M.Bio Med (2014)

Director, Public Drug and Medical Supplies, Ministry of Health, Jakarta, Indonesia

 

Ireland

Michael Barry, MD, PhD, FRCPI (2009 - 2015) Clinical Director, National Centre for Pharmacoeconomics, St. James's Hospital, Dublin, Ireland

Mairin Ryan, BSc, DrPH (2007, 2014 - 2015) Director of Health Technology Assessment, National Centre for Pharmacoeconomics, Dublin, Ireland

 

Italy

Luciana Ballini, PhD (2015) Head, Regional Observatory for Innovation (ORI), Regional Healthcare and Social Agency - Region Emilia-Romagna, Bologna, Italy

Marina Cerbo, ScD (2008, 2015 - 2016) Innovation and Development Director, National Agency for Regional Health Services (AGE.NA.S), Rome, Italy

Americo Cicchetti, PhD (2007) Professor of Health Care Management, Universita Cattolica Del Sacro Cuore, Rome, Italy

Pietro Folino Gallo, MD (2009 - 2011) Director, Medicines Utilisation and Expenditure and HTA Unit, Italian Medicines Agency (AIFA), Rome, Italy

Simona Montilla, PhD, MSc (2013 - 2016) Pharmaceutical Policy Officer, Agenzia Italiana del Farmaco (AIFA), Rome, Italy

 

Japan

Takashi Fukuda, PhD (2012 – 2013, 2016) Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan

Ruoyan Gai, PhD, MSc (2016)
Chief, Division of Policy Evaluation, Department of Health Policy and Chief, Division of Health Technology Assessment, Department of Clinical Epidemiology, National Center for Child Health and Development, Tokyo, Japan

Isao Kamae, MD, DrPH (2008, 2015) Professor of Health Technology Assessment and Public Policy, Graduate School of Public Policy, The University of Tokyo, Tokyo, Japan

Makoto Kobayashi (2008) Director, HTA Division, Crecon R & C, Tokyo, Japan

Naoko Tomita, MA (2014) Senior Researcher, National Institute of Public Health, Department of International Health & Collaboration, Saitama, Japan (TBC)

 

Kazakhstan

Alima Almadiyeva, MD, MSc (2012, 2015 - 2016) Strategic Initiatives Director and Chief Scientist, Kazakh Agency for Health Technology Assessment, Astana, Kazakhstan

Yelzhan Birtanov, MD, PhD, DSc (2015) Advisor of Minister of Health and Social Development Republic of Kazakhstan and CEO PPP Advisory Center, Astana, Kazakhstan

Arman Darbayev, MD (2015) Chief Expert of Standardization of inpatient services division at Department of Medical Services Standardization, Ministry of Health and Social Development, Astana, Kazakhstan

Gauhar Iskakova (2015) Head of Standardization of Outpatient Services Division at Department of Medical Services Standardization, Ministry of Health and Social Development, Astana, Kazakhstan

Alexander Kostyuk, MD, PhD (2011 - 2016) Chair, Health Policy & Health Technology Assessment Department, Almaty State Institute for Continuing Medical Education, and Chief Scientific & Executive Officer, Kazakh Agency for Health Technology Assessment (HTA), Astana, Kazakhstan

Temirkhan Kulkhan, MD, MSc (2015) Deputy Director of Center Standardization and HTA at Republican Center for Health Development, Ministry of Health and Social Development, Astana, Kazakhstan

Larissa Makalkina, MD, PhD (2015) Director, Drug Information and Analytical Center at Republican Center for Health Development, Ministry of Health and Social Development, Astana, Kazakhstan

Talgat Nurgozhin, MD, DSc, PhD (2015) Director of Translational Medicine and Longevity Department, Center for Life Sciences, Nazarbayev University, Astana, Kazakhstan

Alexey Tsoi, MD, PhD (2015) Vice Minister, Ministry of Health and Social Development, Astana, Kazakhstan

Gulnar Tulesheva, MD, PhD (2015) Chief Scientific Officer & Head EBM Centre, Astana Medical University, Astana, Kazakhstan

 

Kyrgyzstan

Bermet Baryktabasova, MD, PhD (2015) National Consultant of Evidence Based Medicine and Development of National Clinical Guidelines and Protocols, Ministry of Health, Bishkek, Kyrgyzstan

 

Latvia

Diāna Arāja (2015 - 2016) Head, Pharmacy Division, Ministry of Health of the Republic of Latvia, Riga, Latvia

 

Lithuania

Gintarė Mikšienė, MSc (2013-2014) Head of Health Technology Division, State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania (VASPVT), Vilnius, Lithuania

Eglė Urbonavičiūtė (2015 - 2016) Chief specialist, deputizing for the Head of Medical Technology Division, State Health Care Accreditation Agency (VASPVT), Vilnius, Lithuania

 

Luxembourg

Nadine Berndt, PhD, MSc (2016)
Scientific Analyst, Medical Expertise Cell, Ministry of Social Security, Luxembourg City, Luxembourg

Juergen Hohmann (2014) Health Economist, Cellule d'expertise médicale Inspection générale de la Securité sociale (IGSS) Luxembourg

 

Macedonia

Zoran Sterjev, PhD (2014) Member of the Chapter Board, ISPOR Republic of Macedonia Regional Chapter Vice-Dean, Faculty of Pharmacy, University St. Cyril and Methodius-Skopje Head, National Drug Information Center Skopje, Republic of Macedonia

 

Malaysia

Syed Mohamed Aljunid, MD, MSc, PhD, FAMM (2008) Professor, Head, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

Rugayah Bakri, MBBCh, MPH (2008) Head, Malaysian HTA Section (MaHTAS), MOH, Kuala Lumpur, Malaysia

Faridah Aryani MD Yusof, PhD (2012 – 2014, 2016) Senior Principle Assistant Director, Ministry of Health, Petalingjaya, Malaysia

Rosliza Lajis (2015) Senior Principal Assistant Director, Formulary and Pharmacoeconomic Branch, Pharmaceutical Services Division, Ministry of Health, Kuala Lumpur, Malaysia

 

Mexico

Jose Luis Aguilar, MD (2011, 2013) Deputy Director, VITAMEDICA, Mexico DF, Mexico

Iris Contreras, MD (2011) Clinical Researcher, Instituto Mexicano del Seguro Social, Delegacion Benito Juarez, Mexico

Cesar Alberto Cruz Santiago, MD, PhD (2015, 2017)
Advisor, Area Medical Director, PEMEX, Mexico City, Mexico

Cecilia De la Luz Hipolito, MA (2013) Deputy Director, Direccion de Evaluacion de Tecnologias para la Salud, CENETEC-Salud, Mexico City, Mexico

Rosa Maria Galindo-Suárez, MHE (2013, 2015, 2017) Prioritization Deputy Director, General Health Care Council, Ministry of Health, Mexico City, Mexico

Veronica Gallegos, Ing. (2013) Deputy Director CENETEC, Ministry of Health, Mexico City, Mexico

Eduardo Gonzales Pier, MD, PhD, MEcon (2013) Executive Director, National Health Foundation (FUNSALUD), Former Director of Finance, Mexican Insitute for Social Security (IMSS), Mexico City, Mexico

Maria Luisa González Rétiz, MA (2011) General Director, CENETEC - National Center for Health Technology Excellence, Mexico City, Mexico

Guillermo Melendez, MD, MSc (2009) Consultant, Mexican Health Foundation, Mexico City, Mexico

Atanacio Valencia-Mendoza, MSc  National Institute of Public Health, Morelos, Mexico

 

The Netherlands

Gepke Delwel, PhD (2008) Policy Advisor, Dutch Health Insurance Board, Diemen, The Netherlands

Wim Goettsch, PhD, MSc (2009 - 2017) Director, EUnetHTA JA3 Directorate, Zorginstituut Nederland (ZIN), Diemen, Netherlands

Saskia Knies, PhD, MPhil (2016)
Pharmacoeconomics Advisor, Zorginstituut Nederland (ZIN), Diemen, The Netherlands

 

New Zealand

Anne Kolbe, ONZM, MBBS (Hons), FRACS, FRCSEng (Hon), FCSHK (Hon), FRCSEd (Hon), MAICD (2016) Executive Director, EXCITE International and Paediatric Surgeon, Auckland Surgical Centre, Auckland, New Zealand

 

Norway

Øyvind Melien, MD, PhD (2015 – 2016) Specialist in Clinical Pharmacology, Chair of Secretariat, Norwegian National System for Managed Introduction of Health Technologies, Specialist Health Services, Dept. of Medical Devices and Medicinal Products, Norwegian Directorate of Health, Oslo, Norway

Berit Mørland, PhD (2007) Deputy Director General, Norwegian Knowledge Centre for the Health Service, Oslo, Norway

Inger Norderhaug (2008) Research Director, Specialist Health Care Unit, Norwegian Knowledge Center for the Health Services, Oslo, Norway

 

Peru

Dra. Gisely Hijar Guerra (2017)
Directora Ejecutiva de Enfermedades No Transmisibles, Instituto Nacional de Salud, Lima, Perú

Henry Miguel Angel Maquera Colque, MBA (2011, 2013) Mayor of Fund Managers Health Financing, National Superintendency, Universal Health Insurance, Lima, Perú

Lucy Nancy Olivares Marcos, MD (2017)
Healthcare Operations Manager, El Seguro Social de Salud (EsSalud), Lima, Peru

Philippines

Melissa Guerrero, MD, MPH (HTA) (2013)

Program Director, National Center for Pharmaceutical Access and Management, Department of Health, Manila, Philippines

Kenneth Hartigan-Go, MD (2012) Director General, Food and Drug Administration, Muntinlupa City, Philippines

Dale Huntington, ScD, Director (2013) Asia Pacific Observatory on Health Systems and Policies, World Health Organization Western Pacific Regional Office, Manila, Philippines

Camille Mendoza (2013) Administrative Associate, Dr. Stephen Zuellig Center, Asian Institute of Management, Manila, Philippines

Merla Rose D. Reyes (2015 – 2016) Senior Social Insurance Specialist, Special Benefits Team, Philippine Health Insurance Corporation, Pasig City, Philippines

Davidson B. The (2013) Program Coordinator, Dr. Stephen Zuellig Center, Asian Institute of Management, Manila, Philippines

Klara Tisocki, PhD (2013) World Health Organization Western Pacific Regional Office, Manila, Philippines

Madeleine Valera, MD, MScIH (2008) Senior Vice President, Health Finance Policy and Services Sector, Philippines Health Insurance Corporation, Pasig City, Philippines

Pura Angela Wee, MD (2013) Head, ISPOR Philippines Chapter Secretariat, Associate Director, Dr. Stephen Zuellig Center, Asian Institute of Management, Manila, Philippines

Jed Cyrus Yparraguirre (2013) Program Associate, Dr. Stephen Zuellig Center, Asian Institute of Management, Manila, Philippines

 

Poland

Zbigniew J. Król, MD, PhD (2008) Deputy Director for Health Technology Assessment, Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland

Iga Lipska, MD (2009 - 2010) Director of Health Technology Assessment Department, Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland

Norbert Wilk, MD (2007) Deputy Director of the Agency, Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland

Anna Zawada (2011 - 2016) Director of the Transparency and Tariff Councils Office, Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland

 

Portugal

João Martins, PharmD, MBA, MSc (2015) Director of Medicines Evaluation Department, National Authority of Medicines and Health Products (INFARMED), Lisbon, Portugal

Isaura Vieira, MD (2009) Head of Medical and Health Products, Economic Department, National Authority of Medicines and Health Products (INFARMED), Lisbon, Portugal

José Vinhas, MD (2016)
President, Portuguese Health Technology Committee, National Authority of Medicines and Health Products (INFARMED), Lisbon, Portugal

 

Russia

Oleg Borisenko, MD (2010) Secretariat Formulary Committee of Russian Academy of Medical Sciences, Executive Director of ISPOR Russia Regional Chapter, Moscow, Russia

Prof. Vitaly Omelianovsky, MD, PhD, DSc (2011 - 2016) Professor and Director, the Center for Health Technology Assessment (HTA) of the Presidential Academy of National Economy and Public Administration, Moscow, Russia

 

Serbia

Dragana Atanasijevic, MD, MSc (2010 – 2011, 2014 - 2016) Assistant Director, Development and Implementation of Pharmacotherapeutic Protocols, National Health Insurance Fund of Serbia, Belgrade, Serbia

 

Singapore

Chein Earn Lee (2008) Senior Director, Healthcare Performance Group, Ministry of Health, Singapore, Singapore

Daphne Khoo, MBBS (2014, 2016) Group Director, Health Performance Group, Ministry of Health, Singapore

 

Slovakia

Tomas Tesar, PharmD, PhD, MBA (2014 - 2016) Member, Reimbursement Committee Working Group for Pharmacoeconomics, Clinical Outcomes, and HTA of the Slovak Ministry of Health Slovak Ministry of Health, Union Health Insurance Fund Bratislava, Slovakia

Martin Višňanský, PharmD, MBA, PhD (2010 - 2014) Director of Health Policy and Strategy SLOVAHTA n.o. Bratislava, Slovakia

 

Slovenia

Jure Mikolic, MA Pharm (2015 - 2016) Pharmacy Manager, Department of Medicine, Health Insurance Institute Slovenia , Ljubljana, Slovenia

Valentina Prevolnik-Rupel, PhD (2012 - 2014) Senior Researcher, Institute of Economic Research, Ljubljana, Slovenia

Eva Turk, MA, MBA (2010 - 2011) Senior Researcher, National Institute of Public Health, Ljubljana, Slovenia

 

South Korea

Eun-Joo Hwang (2015) Deputy Manager, Pharmaceutical Listing Division, Pharmaceutical Benefit Department, Health Insurance Review & Assessment Service, Seoul, South Korea

Junho Jang, PhD, MPH (2013-2014) Deputy Manager, Pharmaceutical Listing Division, Pharmaceutical Benefit Department, Health Insurance Review & Assessment Service, Seoul, South Korea

Kookhee Kim, PhD (2013) Manager, Pharmaceutical Listing Division, Pharmaceutical Benefit Department, Health Insurance Review & Assessment Service, Seoul, South Korea

Namkwen Kim, D.K.M., MPH, PhD (2015 - 2016) Director, Center for Comparative Effectiveness Research & Economic Evaluation in Korean Medicine (CEREEKoM), Professor, Pusan National University, Yangsan, Gyeongnam, South Korea Yoon Kim, MD, PhD (2015)

Sukyeong Kim, PhD (2016 - 2017)
Director, Coordinating Center for National Health Clinical Research in National Evidence-Based Healthcare Collaborating Agency (NECA), Seoul, South Korea

Yoon Kim, MD, PhD (2015) Vice Chairman of the National Mental Health Commission, Ministry of Health and Welfare, and Chairman, Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, South Korea

Donghyo Lee, D.K.M., PhD (2015 - 2016) Assistant Professor, College of Korean Medicine, Woosuk University, Jeonju, Jeonbuk, South Korea

Eui-Kyung Lee, PhD, RPh (2008) Professor, Graduate School of Clinical Pharmacy, Sookmyung Women's University, Seoul, South Korea

Go eun Lee, D.K.M, MSC (2015) Civil servant (Korean medical doctor), Korean National Rehabilitation Center, Seoul, South Korea

Sang-Moo Lee, MD, PhD (2008) Director, Health Technology Assessment Department, Health Insurance Review Assessment and Service, Seoul, South Korea

Seung-Min Lee (2012) Deputy Manager of Drug Listing Division, Health Insurance Review and Assessment Service, Seoul, South Korea

Mi-Hai Park (2012) Associate Research Fellow of Drug Listing Division, Health Insurance Review & Assessment Service, Seoul, South Korea

Soomi So, PhD (2014)

Manager, Pharmaceutical Listing Division, Pharmaceutical Benefit Department, Health Insurance Review & Assessment Service, Seoul, South Korea

Bong-Min Yang, PhD (2008, 2012 - 2013, 2015 - 2016) Professor of Health Economics, School of Public Health, and Executive Director, Institute of Health and Environment, Seoul National University, Seoul, South Korea

Junhyeok Yi, D.K.M, MPH (2015) Senior Researcher (Team Manager), Korean Medicine Policy Research Center, Korea Institute of Oriental Medicine, Daejeon, South Korea

So-Young Yi, PhD (2008) General Manager, Drug Listing Division, Health Insurance Review Assessment and Service, Seoul, South Korea

Mi-Young You (2012) General Manager of Drug Listing Division, Health Insurance Review and Assessment Service, Seoul, South Korea

Spain

Juan-Antonio Blasco Amaro, MD, MPH, MHE, MHTAi (2011 - 2012) Director, Health Technology Assessment Unit (UETS), Fellowship Training Agency, Research and Health Studies, Community of Madrid "Pedro Laín Entralgo”, Madrid, Spain

Cari Almazán (2007) Assistant Director for HTA, Agency for Quality, Research and Assessment in Health, AQuRA Health, Barcelona, Spain

Iñaki Imaz Iglesia, MD, PhD, MPH (2008) Senior Researcher, Agencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud "Carlos III", Madrid, Spain

Antonio Sarria Santamera, MD, PhD, MSc (2011 - 2014) Director, Agencia de Evaluación de Tecnologías Sanitarias, Instituto de Salud "Carlos III", Madrid, Spain

Oriol de Solá-Morales, MD (2009 - 2010) Director of Evaluation Agency of Information, Evaluation and Quality of Health (AIAQS), Barcelona, Spain

Joan Rovira, PhD (2007, 2011) Professor, Emeritus, University of Barcelona, Barcelona, Spain

 

Sweden

Susanna Axelsson, dr. Odont (2015) Acting Director General, Swedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden

Stefan Odeberg (2010) Health Economist, The Dental and Pharmaceutical Benefits Agency, Stockholm, Sweden

 

Switzerland

Kees de Joncheere, PharmD, MBA, MSc (2013) Director, Department of Essential Medicines and Health Products, World Health Organization (WHO), Geneva, Switzerland

Dr. Tessa Tan-Torres Edejer (2016)
Coordinator, Unit on Costs, Effectiveness, Expenditure and Priority Setting, Department of Health Financing and Governance (HGF), World Health Organization, Geneva, Switzerland

Suzanne Hill, B.Med, PhD (2015) Senior Advisor, Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland

Christoph Künzli (2013, 2015) Senior Assistant HTA Activities, Federal Department of Home Affairs, Swiss Federal Office of Public Health, Health and Accident Insurance Directorate, Division of Health Care Services, Medical Services Section, Berne, Switzerland

Matthias Menig, MD (2015) Medical Specialist, Medical Services Section, Swiss Federal Office of Public Health, Health and Accident Insurance Directorate, Berne, Switzerland

Mark Pletscher  (2014) Research Associate Winterthur Institute of Health Economics (ZHAW) Winterthur, Switzerland

Goedele van Haasteren (2014) Federal Department of Home Affairs Swiss Federal Office of Public Health, Health and Accident Insurance Directorate Berne, Switzerland

Adriana Velazquez Berumen, MSc (2016)
Senior Advisor and Focal Point on Medical Devices, World Health Organization, Geneva, Switzerland

 

Taiwan

Raoh-Fang (Jasmine) Pwu, PhD (2012 – 2014, 2016) Senior Investigator, Health Data Research Center, National Taiwan University, Taipei, Taiwan

Mao-Ting Sheen, MSC, MA (2012) Director, Department of Medical Review and Pharmaceutical Benefit, Bureau of National Health Insurance, Taipei, Taiwan

Yen-Huei (Tony) Tarn, MS, PhD (2008, 2012 - 2016) Associate Professor, Kaohsiung Medical University, Kaohsiung, Taiwan

Ming-Chin Yang, PhD (2008) Associate Professor, Medical Administration Institute, National Taiwan University, Taipei, Taiwan

 

Thailand

Thidaporn Jirawattanapisal (2008)  Senior Pharmacist and Researcher, Ministry of Public Health, Thailand, Nonthaburi, Thailand

Suriya Wongkongkathep, MD (2014) Inspector-General, Ministry of Public Health, Nonthaburi, Thailand

Inthira Yamabhai, PhD (2014) Health Intervention and Technology Assessment, Department of Health, Ministry of Public Health, Nonthaburi, Thailand

 

Tajikistan

Shavkiya Pachadzanova, MD, PhD (2015) Professor and Head of Resource Evidence Based Medicine Center, Avicenna Tajik State Medical University, Dushanbe, Tajikistan

 

Turkey

Rabia Kahveci, MD, MScHTA (2014 - 2016) Professor, Ankara Numune Hospital, Chair, ANHTA (Ankara Numune HTA Unit), Consultant, HTA Unit, Ministry of Health (Agency for Pharmaceuticals and Medical Devices), Director, HTAi, Ankara, Turkey

Bilgehan Karadayı, MD (2016)
Head, Health Technology Assessment Department, General Directorate of Health Research, Ministry of Health, Republic of Turkey, Ankara, Turkey

 

Ukraine

Professor Kostyantyn Kosyachenko, PharmD, PhD, DSc (2013-2015) President, Ukrainian Agency for Health Technology Assessment (UAHTA), Head, Department of Pharmacy and Industrial Technology of Drugs, Bogomolets National Medical University, Kyiv, Ukraine

Prof. Alla Stepanenko (2011 - 2013) Deputy Chief, State Formulary Committee, Government Expert Center and Advisor to the Minister of Health, Ministry of Health of Ukraine, Kyiv, Ukraine

 

United Kingdom

Corinne Booth (2014) Senior Health Economist, Scottish Medicines Consortium Healthcare Improvement Scotland Glasgow, UK

Meindert Boysen, PharmD, MSc (2011, 2013 - 2016) Programme Director Technology Appraisals, Centre for Health Technology Evaluation, National Institute for Health and Clinical Excellence (NICE), Manchester, United Kingdom

Debbie Chase, PhD (2006) Senior Research Fellow, EUnetHTA Project National Coordinating, Centre for Health Technology Assessment, Southampton, United Kingdom

Joyce Craig (2008) Lead Health Economist, Health Services Research & Effectiveness Unit, NHS Quality Improvement Scotland, Glasgow, United Kingdom

Sir Andrew Dillon (2012) Chief Executive, National Institute for Health and Clinical Excellence (NICE), London, United Kingdom

Michael F. Drummond, PhD (2006, 2013) Professor of Health Economics, Centre for Health Economics, University of York, York, United Kingdom

Hans-Georg Eichler, MD, MSc (2010) Professor, Senior Medical Officer, European Medicines Agency (EMA), London, United Kingdom

Elisabeth George, PhD (2012) Associate Director, Technology Appraisals, National Institute for Health and Clinical Excellence (NICE), Manchester, United Kingdom

Anne Lee (2015) Chief Pharmacist, Scottish Medicines Consortium, Glasgow, Scotland

Carole M. Longson, PhD (2009 - 2010) Director, Centre for Health Technology Evaluation, National Institute for Health and Clinical Excellence (NICE), Manchester, United Kingdom

Karen Macpherson (2013) Lead Health Services Researcher, NHS Quality Improvement Scotland, Glasgow, United Kingdom

Mirella Marlow, MA, MBA (2015) Program Director, Devices and Diagnostic Systems, National Institute for Health and Clinical Excellence (NICE), London, United Kingdom

Jeremiah Mwangi (2012) Policy and External Affairs Director, The International Alliance of Patients Organizations, London, United Kingdom

Sara Twaddle, PhD (2016)
Director of Evidence, Healthcare Improvement Scotland, Glasgow, Scotland

 

USA

Elizabeth Adams, RRT, MPH (2007, 2009 - 2010) Research Analyst, VA Tech Assess Program [VATAP], Boston, MA, USA

Dan Allen, PharmD (2013) Clinical Pharmacist Consultant, RegenceRx, Portland, OR, USA

Sherry Andes, BS Pharm, PharmD, BCPS, BCPP, PAHM (2013 - 2015) Sr. Manager, Pipeline and Trend Surveillance, Catamaran, Louisville, Kentucky, USA

Naomi Aronson, PhD (2008 - 2009) Executive Director, Blue Cross Blue Shield Association, Technology Evaluation Center, Chicago, IL, USA

Suzanne Belinson, PhD, MPH (2011, 2016 - 2017) Executive Director, Center for Clinical Effectiveness, Blue Cross Blue Shield Association, Chicago, IL, USA

Elise Berliner, PhD (2016 - 2017) Director, Technology Assessment Program, Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA

Stephen J. Boccuzzi, PhD, MBA (2010 - 2011) Vice President, Medco Health, Franklin Lakes, NJ, USA

Diana Brixner, RPh, PhD (2006 - 2007) 2007-2008 ISPOR President, and Associate Professor & Chair, Department of Pharmacotherapy, and Executive Director, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT, USA

Elizabeth Brusig, PharmD, MBA (2013) Clinical Pharmacy Specialist, Optima Health Plan, Sentara Healthcare, Virginia Beach, VA, USA

Laurie Burke, RPh, MPH (2014) Founder, LORA Group, LLC, Royal Oak, MD, USA

Francisco Caccavo, PhD (2015) Pan American Health Organization (PAHO), Washington, DC, USA

Jennifer Chang, PharmD, MPH (2017) Supervisor, Drug Information Services, Coordinator, SCPMG Regional P&T Committee, Kaiser Permanente Drug Services, Downey, CA, USA

Jon Clouse, RPh, MS (2010) Director, Pharmacoeconomic Evaluations, UnitedHealthCare, Brevard, NC, USA

Vivian H. Coates, MBA (2007 - 2009) Vice President, Information Services and Technology Assessment, ECRI Institute, Plymouth Meeting, PA, USA

Jessica Daw, PharmD, MBA (2013 - 2017) Director of Pharmacy, UPMC Health Plan, Pittsburgh, PA, USA

Mary Durham, PhD, MA, BA (2007 - 2010) Vice President, Research, Kaiser Foundation Hospitals, Portland, OR, USA

Bernadette Eichelberger, PharmD (2013) Director, Pharmacy Affairs, Academy of Managed Care Pharmacy (AMCP), Alexandria, VA, USA

Maria-Luisa Escobar, MD (2011) Manager, Health Systems Practice, World Bank, Washington, DC, USA

Leslye K. Fitterman, PhD (2009) Office of Clinical Standards & Quality Coverage & Analysis Group, Center for Medical Technology Policy, Baltimore, MD, USA

Sharon Frazee, PhD, MPH (2012 - 2015) Vice President of Research and Education, Pharmacy Benefit Management Institute, Plano, TX, USA

Patrick Gleason, PharmD, BCPS, FCCP (2016) Director, Health Outcomes, Prime Therapeutics, Minneapolis, MN, USA

Rochelle Henderson, PhD (2015-2016) Sr. Director Research and Analytics, Express Scripts, Inc., St. Louis, MO, USA

Lynn Hudson, PhD (2010) Director, DHHS/NIH/OD/OSP/OSPA, National Institute of Health, Bethesda, MD, USA

Louis B. Jacques, MD (2010 - 2011) Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services, Baltimore, MD, USA

Saira Jan, PharmD, MS (2017) Director Clinical Pharmacy Program Management, Horizon Blue Cross Blue Shield, Newark, NJ, USA

Cheryl Kaltz, RPh, MBA (2013) Lead Clinical Pharmacist, the University of Michigan Prescription Drug Plan, University of Michigan, Ann Arbor, MI, USA

Sean Karbowicz, PharmD (2014 - 2017) General Manager, MedSavvy, Portland, OR, USA

Nicholas G. LaRocca, PhD (2012) Vice President, Health Care Delivery and Policy Research, National Multiple Sclerosis Society, New York, NY

Lieutenant Commander Joseph Lawrence (2010) Deputy Director, Pharmacoeconomic Center, Department of Defense, San Antonio, TX, USA

William Lawrence, DrPH (2007) Director, Agency for Healthcare Research and Quality, Rockville, MD, USA

Alexandre Lemgruber, MSc (2009, 2011, 2013) Advisor for Health Technology Management, Pan American Health Organization (PAHO), Washington, DC, USA

Maria Lopes, MD, MS (2017) Chief Medical Officer, Magellan Rx Management, Scottsdale, AZ, USA

Andrea Marks, MS (2016) Chief Analytics Officer, OptumRx, Chicago, IL, USA

Dell Mather, PharmD (2014) VP of Trend Programs, CVS Caremark, Minneapolis, MN, USA

Denis Matsuoka, PharmD (2017) Vice President, Clinical & Formulary Services, OptumRx, Irvine, CA, USA

Craig Mattson, MS, MBA, RPh (2017) Senior Director, Formulary Development, Prime Therapeutics, Minneapolis, MN, USA

Karl Matusewski, MS, PharmD (2007 - 2009) Vice President, Editor-in-Chief, Elsevier / Gold Standard, Tampa, FL USA

Marian McDonagh, PharmD (2007, 2009) Principal Investigator, Evidence-Based Practice Center, Drug Effectiveness Review Project (DERP), Portland, OR, USA

Nancy E. Miller, PhD (2011) Executive Secretary, Trans-NIH CER Coordinating Committee, Senior Science Analyst, Office of the Director, National Institute of Health, Bethesda, MD, USA

Penny Mohr, MA (2008) Director, Division of Research on Health Plans and Drugs, Centers for Medicare and Medicaid Services, Baltimore, MD, USA

Josh Morse, MPH (2016 - 2017) Program Director, Washington State Health Technology Assessment Program, Washington State Health Care Authority, Olympia, WA, USA

Shawn Nowicki, MPH (2011) Director Health Policy, Northeast Business Group on Health, New York, NY, USA

Steven D. Pearson, MD, MSc (2015-2017) President, Institute for Clinical and Economic Review, Boston, MA USA

Steve Phurrough, MD, MPA (2007, 2010 - 2011) Chief Operating Office/Senior Clinical Director, Center for Medical Technology Policy, Baltimore, MD, USA

Scott Ramsey, PhD, MD (2006) Associate Director, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

William Repicci (2012) Executive Director, Lymphatic Research Foundation, Glen Cove, NY

Carly Rodriguez, PharmD (2013, 2017) Pharmacy Director, Clinical Innovation, Moda Health, Portland, OR, USA

Teresa Rogstad, MPH (2007 - 2009) Medical Research Analyst, Hayes, Inc., Louisville, KY, USA

Carolyn Rohrs, PharmD (2017) Clinical Pharmacist Consultant, Pharmacy Services, OmedaRx, Seattle, WA, USA

Elan Rubinstein, PharmD, MPH (2011)  EB Rubinstein Associate, Representing Midatlantic Business Group on Health, Greenbelt, MD, USA

Jerome Seidenfeld, PhD  (2007) Associate Director, Blue Cross Blue Shield Association, Technology Evaluation Center, Chicago, IL, USA

Helen Sherman, PharmD (2013) Chief Pharmacy Officer of Pharmacy Services, RegenceRx, Portland, OR, USA

Michael Sherman, MD (2017) Senior Vice President & Chief Medical Officer, Harvard Pilgrim Health Care, Wellesley, MA, USA

Chuck Shih, PhD (2016) Senior Officer, Specialty Drugs, The Pew Charitable Trusts, Washington, DC, USA

Brian K. Solow, MD, FAAFP (2013 - 2014, 2016) Chief Medical Officer, Optum Life Sciences, Irvine, CA, USA

Jean Slutsky, PA, MSPH (2010, 2012) Director, Center for Outcomes & Evidence, Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA

Debbie Stern, RPh (2014) President, Rxperts, Anaheim Hills, CA, USA

Karen Stockl, PharmD (2015, 2017) Director, Health Economics and Outcomes Research, Optum, Irvine, CA, USA

Donna Sullivan, PharmD, MS (2016 - 2017) Chief Pharmacy Officer, Washington State Prescription Drug Program, Washington State Health Care Authority, Olympia, WA, USA

Tamara Syrek Jensen, JD (2010 - 2011) Deputy Director, Coverage and Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Baltimore, MD, USA

Leonardo Cubillos Turriago, MD, MPH (2011) Consultant, World Bank Institute, Washington, DC, USA

Nancy Barker Walczak, FSA, PhD, MAAA (2009 - 2011) Managing Director for Actuarial Consulting, Ingenix Consulting, Eden Prairie, MN, USA

John Watkins, RPh, MPH (2007 - 2017) Pharmacy Manager, Formulary Development, Premera Blue Cross, Bothell, WA, USA

Jeffrey White, MS, PharmD (2010 - 2014, 2016) Director, Drug Evaluation and Clinical Analytics, Wellpoint, Inc., Newport Coast, CA, USA

Karen Worley, PhD (2013 - 2016) Research Leader, Comprehensive Health Insights, Humana, Inc., Cincinnati, OH, USA

Winnie Yang, PharmD (2013) Director, Pharmacy Product, Strategy and Analytics Blue Shield of California Woodland Hills, CA, USA

 

Uruguay

Francisco E. Estevez-Carrizo, MD (2017)
Vice President, HTA Committee, National Board of Health of the Armed Forces (D.N.S.FF.AA.), Montevideo, Uruguay

Ana Perez, MD (2013) Directora de Evaluacion Sanitaria, Ministerio de Salud de Uruguay, Montevideo, Uruguay

Alarico Rodriguez, MD (2009, 2011, 2013, 2015, 2017) Medical Benefits Manager, Uruguayan National Agency for Highly Specialized Medical Procedures, Montevido, Uruguay

 

Uzbekistan

Nizom Suyunov, PhD (2015) Docent, Department of Pharmacy Organization, Tashkent Pharmaceutical Institute, Tashkent, Uzbekistan

 

Venezuela

Yajaira Bastardo, PhD (2009) Professor, Central University of Venezuela, Caracas, Venezuela

Marino J. Gonzalez, PhD, MSc (2009) Professor Economic and Administrative Sciences, Simon Bolivar University, Caracas, Venezuela

Gustavo Villasmil, MD, PhD (2013) Secretario de Salud del Estado Bolivariano de Miranda, Ministerio de Salud, Caracas, Venezuela

 


HTA Roundtables